Henry Schein to Participate in Investor Conferences in November
MELVILLE, N.Y.--(BUSINESS WIRE)--Oct 24, 2024--
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November:
- Stifel’s Healthcare Conference at Lotte New York Palace Hotel, New York, on November 18, 2024, at 9:45 a.m. Eastern Standard Time.
- Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. Greenwich Mean Time/8:30 a.m. Eastern Standard Time.
Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241023243824/en/
CONTACT: Investors
Ronald N. South
Senior Vice President and Chief Financial Officer
ronald.south@henryschein.com
(631) 843-5500Graham Stanley
Vice President, Investor Relations and Strategic Financial Project Officer
graham.stanley@henryschein.com
(631) 843-5500Media
Ann Marie Gothard
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL SUPPLIES GENERAL HEALTH HEALTH MEDICAL DEVICES HEALTH TECHNOLOGY DENTAL OTHER HEALTH
SOURCE: Henry Schein, Inc.
Copyright Business Wire 2024.
